High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. - van Dorp J; Pipinikas C; Suelmann BBM; Mehra N; van Dijk N; Marsico G; van Montfoort ML; Hackinger S; Braaf LM; Amarante T; van Steenis C; McLay K; et al. (Nature medicine, 2023)